• Pharmx renews long-standing National Diabetes Services Scheme (NDSS) agreement
• Secures partnerships with over 50 new suppliers across Australia and New Zealand
• New supplier partners include Homart (AU), Healthylife (AU), Edgewell (NZ), and Solgar (NZ)

Pharmx Technologies (ASX:PHX) is pleased to report that it has renewed its long-standing agreement with the National Diabetes Services Scheme (NDSS), with a 12-month extension to the existing arrangement commencing 1 July, 2025. This renewal reflects the continued confidence of key health stakeholders in the Pharmx platform and underscores its role as essential digital infrastructure within Australia's healthcare supply chain. NDSS ordering remains one of the most frequent and operationally embedded digital workflows in Australian pharmacies, and its continued integration with the Pharmx network affirms the platform's relevance to core pharmacy operations and national health service delivery. As part of its FY25 focus on expanding Supplier Growth, Pharmx has secured partnerships with over 50 new suppliers across Australia and New Zealand, bringing the total number of active suppliers on the Pharmx platform to more than 170. This momentum reflects Pharmx's strategic objective to enhance platform utility, improve pharmacy engagement, and sustain commercial performance. The new supplier partners include Homart (AU), Healthylife (AU), Edgewell (NZ), and Solgar (NZ), bringing high-demand, category-leading products to the platform and enhancing pharmacy access to essential stock while driving increased transaction volume and order frequency across the Pharmx network.

Through the renewal of a key national health partnership and the ongoing expansion of its supplier base, Pharmx continues to strengthen its leadership as the region's most connected pharmacy ordering network.